← Leaderboards
Nancy Joan Raab-Traub
University Of North Carolina Chapel Hill
$18,607,374
Attributed
$18,607,374
Total exposure
17
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.2M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$58,551,960 · 18
By mechanism
P01$47,540,152 · 8
R01$8,522,507 · 4
P30$2,429,653 · 4
R13$59,648 · 2
Top collaborators
- Blossom A Damania17 shared
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- Joseph S Pagano$26,597,625
Others in their field
Top investigators on “Property”
- Mitchell J Malone · Texas A&M Research Foundation$344,583,004
- Gary D Acton · University Of California-Davis$320,373,312
- Everette D Joseph · Howard University$250,079,293
- Valerie Koch · University Corporation For Atmospheric Res$247,762,266
- Antonio J Busalacchi · University Of Maryland, College Park$243,972,016
- Eric J Barron · Pennsylvania State Univ University Park$243,972,016
Research focus
PropertyCell GrowthSignal PathwayGene ExpressionProgramsViral ProteinsMalignant NeoplasmsTumorigenesisProteinsHuman Herpesvirus 4Pathway InteractionsTumorCellsMembrane ProteinsSignal TransductionAffectGenesGrowthMolecularMicrornasViralVirusHuman Herpesvirus 8Mediating
Grant awards (117)
Viral Oncogenesis, Latency, and Replication$1,936,921
P01 · FY2025 · CA
Tumorigenesis by the Epstein Barr Virus$347,155
P01 · FY2025 · CA · contact PI
Viral Oncogenesis, Latency, and Replication$1,936,921
P01 · FY2024 · CA
Tumorigenesis by the Epstein Barr Virus$347,155
P01 · FY2024 · CA · contact PI
Viral Oncogenesis, Latency, and Replication$1,936,921
P01 · FY2023 · CA
Tumorigenesis by the Epstein Barr Virus$347,155
P01 · FY2023 · CA · contact PI
Viral Oncogenesis, Latency, and Replication$1,936,921
P01 · FY2022 · CA
Tumorigenesis by the Epstein Barr Virus$347,155
P01 · FY2022 · CA · contact PI
Herpesviral Oncogenesis, Latency and Reactivation$1,812,045
P01 · FY2020 · CA
Project 5 - Transformation by EBV Latent Membrane Proteins 1 and 2$286,828
P01 · FY2020 · CA · contact PI
Virology Research Program (Program 4)$46,591
P30 · FY2020 · CA · contact PI
Herpesviral Oncogenesis, Latency and Reactivation$1,757,717
P01 · FY2019 · CA
Project 5 - Transformation by EBV Latent Membrane Proteins 1 and 2$279,066
P01 · FY2019 · CA · contact PI
Herpesviral Oncogenesis, Latency and Reactivation$63,936
P01 · FY2019 · CA
Virology Research Program (Program 4)$45,159
P30 · FY2019 · CA · contact PI
Project 5 - Transformation by EBV Latent Membrane Proteins 1 and 2$9,133
P01 · FY2019 · CA · contact PI
Herpesviral Oncogenesis, Latency and Reactivation$1,812,080
P01 · FY2018 · CA
Project 5 - Transformation by EBV Latent Membrane Proteins 1 and 2$286,831
P01 · FY2018 · CA · contact PI
Herpesviral Oncogenesis, Latency and Reactivation$63,936
P01 · FY2018 · CA
Virology Research Program (Program 4)$46,589
P30 · FY2018 · CA · contact PI
Project 5 - Transformation by EBV Latent Membrane Proteins 1 and 2$9,133
P01 · FY2018 · CA · contact PI
Virology Research Program (Program 4)$2,968
P30 · FY2018 · CA · contact PI
Virology Research Program (Program 4)$2,101
P30 · FY2018 · CA · contact PI
Virology Research Program (Program 4)$1,366
P30 · FY2018 · CA · contact PI
Herpesviral Oncogenesis, Latency and Reactivation$1,812,080
P01 · FY2017 · CA
Project 5 - Transformation by EBV Latent Membrane Proteins 1 and 2$314,795
P01 · FY2017 · CA · contact PI
Herpesviral Oncogenesis, Latency and Reactivation$63,936
P01 · FY2017 · CA
Virology Research Program (Program 4)$45,704
P30 · FY2017 · CA · contact PI
Herpesviral Oncogenesis, Latency and Reactivation$1,811,800
P01 · FY2016 · CA
Project 5 - Transformation by EBV Latent Membrane Proteins 1 and 2$314,876
P01 · FY2016 · CA · contact PI
Virology Research Program (Program 4)$45,983
P30 · FY2016 · CA · contact PI
Herpesviral, Oncogenesis, Latency and Reactivation$1,832,044
P01 · FY2015 · CA · contact PI
Transformation by EBV Latent Membrane Proteins 1 and 2 (LMP1 and LMP2)$291,373
P01 · FY2015 · CA · contact PI
Virology$173,150
P30 · FY2015 · CA · contact PI
Virology$163,821
P30 · FY2015 · CA · contact PI
Administration$125,325
P01 · FY2015 · CA · contact PI
Herpesviral, Oncogenesis, Latency and Reactivation$1,777,079
P01 · FY2014 · CA · contact PI
EBV Expression in Nasopharyngeal Carcinoma$288,996
R01 · FY2014 · CA · contact PI
EBV BART miRNAs: Identification of Targets and Characterization of the Effects o$287,693
R01 · FY2014 · CA · contact PI
Transformation by EBV Latent Membrane Proteins 1 and 2 (LMP1 and LMP2)$283,521
P01 · FY2014 · CA · contact PI
Virology$163,459
P30 · FY2014 · CA · contact PI
Virology$153,315
P30 · FY2014 · CA · contact PI
Administration$117,476
P01 · FY2014 · CA · contact PI
Herpesviral, Oncogenesis, Latency and Reactivation$1,722,119
P01 · FY2013 · CA · contact PI
EBV Expression in Nasopharyngeal Carcinoma$280,058
R01 · FY2013 · CA · contact PI
EBV BART miRNAs: Identification of Targets and Characterization of the Effects o$278,795
R01 · FY2013 · CA · contact PI
Transformation by EBV Latent Membrane Proteins 1 and 2 (LMP1 and LMP2)$273,889
P01 · FY2013 · CA · contact PI
Virology$170,078
P30 · FY2013 · CA · contact PI
Virology$160,148
P30 · FY2013 · CA · contact PI
Administration$117,806
P01 · FY2013 · CA · contact PI
Herpesviral, Oncogenesis, Latency and Reactivation$1,832,043
P01 · FY2012 · CA · contact PI
EBV Expression in Nasopharyngeal Carcinoma$297,934
R01 · FY2012 · CA · contact PI
EBV BART miRNAs: Identification of Targets and Characterization of the Effects o$296,590
R01 · FY2012 · CA · contact PI
Transformation by EBV Latent Membrane Proteins 1 and 2 (LMP1 and LMP2)$291,372
P01 · FY2012 · CA · contact PI
Virology$187,175
P30 · FY2012 · CA · contact PI
Virology$178,025
P30 · FY2012 · CA · contact PI
Administration$125,328
P01 · FY2012 · CA · contact PI
Virology$2,552
P30 · FY2012 · CA · contact PI
Virology$2,552
P30 · FY2012 · CA · contact PI
Herpesviral, Oncogenesis, Latency and Reactivation$1,832,038
P01 · FY2011 · CA · contact PI
EBV Expression in Nasopharyngeal Carcinoma$297,934
R01 · FY2011 · CA · contact PI
EBV BART miRNAs: Identification of Targets and Characterization of the Effects o$296,590
R01 · FY2011 · CA · contact PI
Transformation by EBV Latent Membrane Proteins 1 and 2 (LMP1 and LMP2)$291,372
P01 · FY2011 · CA · contact PI
Virology$187,746
P30 · FY2011 · CA · contact PI
Virology$177,887
P30 · FY2011 · CA · contact PI
Administration$125,327
P01 · FY2011 · CA · contact PI
EBV Expression in Nasopharyngeal Carcinoma$307,149
R01 · FY2010 · CA · contact PI
EBV BART miRNAs: Identification of Targets and Characterization of the Effects o$305,763
R01 · FY2010 · CA · contact PI
Herpesviral Oncogenesis, Latency and Reactivation$1,586,373
P01 · FY2009 · CA · contact PI
TRANSFORMATION BY EBV LATENT MEMBRANE PROTEINS 1 AND 2 (LMP1 AND LMP2)$360,885
P01 · FY2009 · CA · contact PI
EBV Expression in Nasopharyngeal Carcinoma$291,685
R01 · FY2009 · CA · contact PI
Herpesviral Oncogenesis, Latency and Reactivation$245,036
P01 · FY2009 · CA · contact PI
Herpesviral Oncogenesis, Latency and Reactivation$1,544,676
P01 · FY2008 · CA · contact PI
TRANSFORMATION BY EBV LATENT MEMBRANE PROTEINS 1 AND 2 (LMP1 AND LMP2)$350,326
P01 · FY2008 · CA · contact PI
Epstein-Barr Virus: Activation of WNT$307,976
R01 · FY2008 · CA · contact PI
EBV Expression in Nasopharyngeal Carcinoma$291,685
R01 · FY2008 · CA · contact PI
Herpesviral Oncogenesis, Latency and Reactivation$1,533,316
P01 · FY2007 · CA · contact PI
TRANSFORMATION BY EBV LATENT MEMBRANE PROTEINS 1 AND 2 (LMP1 AND LMP2)$346,813
P01 · FY2007 · CA · contact PI
Epstein-Barr Virus: Activation of WNT$307,976
R01 · FY2007 · CA · contact PI
EBV Expression in Nasopharyngeal Carcinoma$291,685
R01 · FY2007 · CA · contact PI
Herpesviral Oncogenesis, Latency and Reactivation$1,535,783
P01 · FY2006 · CA · contact PI
Epstein-Barr Virus: Activation of WNT$317,174
R01 · FY2006 · CA · contact PI
EBV Expression in Nasopharyngeal Carcinoma$300,397
R01 · FY2006 · CA · contact PI
TRANSFORMATION BY EBV LATENT MEMBRANE PROTEINS 1 AND 2$231,869
P01 · FY2006 · CA · contact PI
Tumor-Associated Herpesviruses Conference$14,648
R13 · FY2006 · CA · contact PI
Herpesviral Oncogenesis, Latency and Reactivation$1,527,206
P01 · FY2005 · CA
Epstein-Barr Virus: Activation of WNT$324,806
R01 · FY2005 · CA
EBV Expression in Nasopharyngeal Carcinoma$307,626
R01 · FY2005 · CA
TRANSFORMATION BY EBV LATENT MEMBRANE PROTEINS 1 AND 2$225,115
P01 · FY2005 · CA
ADMINISTRATION CORE$49,647
P01 · FY2005 · CA
Epstein-Barr Virus: Activation of WNT$324,806
R01 · FY2004 · CA
EBV EXPRESSION IN NASOPHARYNGEAL CARCINOMA$290,764
R01 · FY2004 · CA
AIDS ASSOCIATED LEUKOPLAKIA--ROLE OF EBV$213,239
R01 · FY2004 · DE
HERPESVIRAL ONCOGENESIS, LATENCY AND REACTIVATION$206,400
P01 · FY2004 · CA
Tumor-Associated Herpesviruses Conference$15,000
R13 · FY2004 · CA
HERPESVIRAL ONCOGENESIS, LATENCY AND REACTIVATION$1,512,798
P01 · FY2003 · CA
EBV EXPRESSION IN NASOPHARYNGEAL CARCINOMA$290,764
R01 · FY2003 · CA
AIDS ASSOCIATED LEUKOPLAKIA--ROLE OF EBV$213,239
R01 · FY2003 · DE
HERPESVIRAL ONCOGENESIS, LATENCY AND REACTIVATION$1,474,400
P01 · FY2002 · CA
TRANSFORMATION BY EBV LATENT MEMBRANE PROTEIN 1$434,203
P01 · FY2002 · CA
EBV EXPRESSION IN NASOPHARYNGEAL CARCINOMA$290,764
R01 · FY2002 · CA
AIDS ASSOCIATED LEUKOPLAKIA--ROLE OF EBV$213,239
R01 · FY2002 · DE
CORE--HUMAN TUMOR MODELS$157,506
P30 · FY2002 · CA
Tumor-Associated Herpesviruses Conference$15,000
R13 · FY2002 · CA
HERPESVIRAL ONCOGENESIS, LATENCY AND REACTIVATION$1,437,125
P01 · FY2001 · CA
TRANSFORMATION BY EBV LATENT MEMBRANE PROTEIN 1$434,203
P01 · FY2001 · CA
EBV EXPRESSION IN NASOPHARYNGEAL CARCINOMA$290,764
R01 · FY2001 · CA
AIDS ASSOCIATED LEUKOPLAKIA--ROLE OF EBV$213,239
R01 · FY2001 · DE
CORE--HUMAN TUMOR MODELS$158,272
P30 · FY2001 · CA
CORE--HUMAN TUMOR MODELS$157,506
P30 · FY2001 · CA
HERPESVIRAL ONCOGENESIS, LATENCY AND REACTIVATION$1,400,936
P01 · FY2000 · CA
EBV EXPRESSION IN NASOPHARYNGEAL CARCINOMA$289,938
R01 · FY2000 · CA
TRANSFORMATION BY EBV LATENT MEMBRANE PROTEIN 1$230,434
P01 · FY2000 · CA
AIDS ASSOCIATED LEUKOPLAKIA--ROLE OF EBV$213,239
R01 · FY2000 · DE
TUMOR ASSOCIATED HERPESVIRUSES CONFERENCE$15,000
R13 · FY2000 · CA
CORE--HUMAN TUMOR MODELS$0
P30 · FY2000 · CA
CORE--HUMAN TUMOR MODELS$0
P30 · FY2000 · CA